ResearcherDuke UniversityActive in the last 2 years
Sabino Zani
Matched on ORCID iD 0000-0003-1939-4778; OpenAlex author ID A5022205133. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 32
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 5
- A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. Co-author DOI 10.1007/s00262-025-04146-5↗
- Genome-based classification of pancreatic acinar cell carcinoma reveals similarities to KRAS wild-type PDAC. Co-author DOI 10.1186/s12967-025-07381-7↗
- Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemotherapy. Co-author DOI 10.1245/s10434-023-13318-5↗
- CT Radiomic Features of Superior Mesenteric Artery Involvement in Pancreatic Ductal Adenocarcinoma: A Pilot Study. Co-author DOI 10.1148/radiol.2021210699↗
- Improved overall survival is still observed in patients receiving delayed adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Last author DOI 10.1016/j.hpb.2020.03.006↗
Closest collaborators
The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dan German Blazer · 4 shared papers, 2020–2025 · strength 0.71
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Paper Genome-based classification of pancreatic acinar cell carcinoma reveals similarities to KRAS wild-type PDAC. DOI 10.1186/s12967-025-07381-7↗
- Paper Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemoth… DOI 10.1245/s10434-023-13318-5↗
- Michael E. Lidsky · 3 shared papers, 2023–2025 · strength 0.59
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Paper Genome-based classification of pancreatic acinar cell carcinoma reveals similarities to KRAS wild-type PDAC. DOI 10.1186/s12967-025-07381-7↗
- Paper Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemoth… DOI 10.1245/s10434-023-13318-5↗
- Peter J. Allen · 2 shared papers, 2023–2025 · strength 0.39
- Paper Genome-based classification of pancreatic acinar cell carcinoma reveals similarities to KRAS wild-type PDAC. DOI 10.1186/s12967-025-07381-7↗
- Paper Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemoth… DOI 10.1245/s10434-023-13318-5↗
- Austin M. Eckhoff · 2 shared papers, 2023–2025 · strength 0.39
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Paper Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemoth… DOI 10.1245/s10434-023-13318-5↗
- Elishama N. Kanu · 2 shared papers, 2023–2025 · strength 0.39
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Paper Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemoth… DOI 10.1245/s10434-023-13318-5↗
- Daniel P. Nussbaum · 2 shared papers, 2023–2025 · strength 0.39
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Paper Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemoth… DOI 10.1245/s10434-023-13318-5↗
- Vinod P. Balachandran · 1 shared paper, 2025 · strength 0.20
- Julia Button · 1 shared paper, 2025 · strength 0.20
- Mengyuan Liu · 1 shared paper, 2025 · strength 0.20
- Kevin C. Soares · 1 shared paper, 2025 · strength 0.20
- Michael Ian D'Angelica · 1 shared paper, 2025 · strength 0.20
- Tao Wang · 1 shared paper, 2025 · strength 0.20
- Erika J. Crosby · 1 shared paper, 2025 · strength 0.20
- Nicholas D. Klemen · 1 shared paper, 2025 · strength 0.20
- Jeffrey A. Drebin · 1 shared paper, 2025 · strength 0.20
- Ethan S. Agritelley · 1 shared paper, 2025 · strength 0.20
- Diane L. Reidy‐Lagunes · 1 shared paper, 2025 · strength 0.20
- Peter J. Allen · 1 shared paper, 2025 · strength 0.20
- William R. Jarnagin · 1 shared paper, 2025 · strength 0.20
- T. Peter Kingham · 1 shared paper, 2025 · strength 0.20
- Alice Chia-Chi Wei · 1 shared paper, 2025 · strength 0.20
- Alex B. Blair · 1 shared paper, 2025 · strength 0.20
- James L. Abbruzzese · 1 shared paper, 2020 · strength 0.12
- Mohamed A. Adam · 1 shared paper, 2020 · strength 0.12
- Megan C. Turner · 1 shared paper, 2020 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.